Method for treating hyperlipidemia

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S311000

Reexamination Certificate

active

07459447

ABSTRACT:
Provided is a method for treating hyperlipidemia or hypercholesterolemia, which comprises administering effective doses of ezetimibe and pitavastatin or a salt or lactone derivative thereof.

REFERENCES:
patent: 5011930 (1991-04-01), Fujikawa et al.
patent: 5102888 (1992-04-01), Fujikawa et al.
patent: 5185328 (1993-02-01), Fukikawa et al.
patent: 5661145 (1997-08-01), Davis
patent: 5854259 (1998-12-01), Fujikawa et al.
patent: 5856336 (1999-01-01), Fujikawa et al.
patent: 5872130 (1999-02-01), Fujikawa et al.
patent: 6465477 (2002-10-01), Muramatsu et al.
patent: 6777552 (2004-08-01), Niddam-Hildesheim et al.
patent: 2004/0126423 (2004-07-01), Moore et al.
patent: 2004/0254120 (2004-12-01), Fogelman et al.
patent: 8-505141 (1996-06-01), None
patent: WO 95/08532 (1995-03-01), None
Harry R. Davis Jr. et al., “The Synergistic Hypocholesterolemic Activity of the Potent Cholesterol Absorption Inhibitor, Ezetimibe. In Combination With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Dogs”, Metabolism, vol. 50, No. 10, Oct. 2001, pp. 1234-1241.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating hyperlipidemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating hyperlipidemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating hyperlipidemia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4040560

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.